Socio-Demographic Status of Patients with Chronic Kidney Diseases

Background: Chronic kidney disease (CKD) is a non-communicable disease that includes a range of different physiological disorders that are associated with abnormal renal function and progressive decline in the glomerular filtration rate (GFR). Chronic kidney disease (CKD) is the 16th leading cause of years of life lost worldwide. Like other developing countries, the prevalence of chronic disease is increasing trends in Bangladesh. Prior conception regarding the socio-demographic status of patients with chronic kidney diseases may be helpful for respective health professionals and researchers. Aim of the study: This study aimed to evaluate the socio-demographic status of patients with chronic kidney diseases. Methods: This was a descriptive cross-sectional study that was conducted in the Department of Medicine and Nephrology, Dhaka Medical College & Hospital (DMCH), Dhaka, Bangladesh during the period from January March 2018 to September 2020. A total of 150 diagnosed cases of CKD were enrolled in this study as a study population. Properly written consent was taken from all the participants before data collection. All data were processed, analyzed, and disseminated by using MS Excel and SPSS version 23.0 program as per necessity. Results: In this study, male participants were dominant in number and the male-female ratio was 1.7:1. The mean age of the respondents was 53.31±10.28 years. The highest number of our participants were unemployed 65(43.3%) and the majority of our respondents 106(70.7%) were married. Among the total participants 83(55.3%) patients were with hypermagnesemia whereas 10(6.7%) with hypomagnesemia. In this current study, among the total respondents 51(34%) had CKD stage 5, 42(28%) had CKD stage 4, 38(25.3%) had CKD stage 3, 14(9.4%) had CKD stage 2 and only 5(3.3%) had CKD stage 1. Conclusion: As per the findings of this study, we can conclude that male people are prone to chronic kidney diseases (CKD). Early investigation and proper treatment can decrease the occurrence of CKD as well as the mortality and morbidity of such theses.